South & Central America Rapid Test Kit Market Forecast to 2030 - Regional Analysis - by Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), and End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others)
The South & Central America rapid test kit market was valued at US$ 926.12 million in 2022 and is expected to reach US$ 1,295.57 million by 2030; it is estimated to record a CAGR of 4.3% from 2022 ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe South & Central America rapid test kit market was valued at US$ 926.12 million in 2022 and is expected to reach US$ 1,295.57 million by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030.Increasing Preference for PCR Techniques Bolster South & Central America Rapid Test Kit Market In recent years, molecular methods such as PCR have evolved as more effective diagnostic tools, as they aid in the precise diagnosis of a wide range of infectious diseases. Most of the popular molecular tests use reverse transcription polymerase chain reaction (RT-PCR). The technique provides reproducible results that are comparable between different laboratories and hence are accepted worldwide. The manufacturers are involved in new PCR developments. For instance, GeneSoC is a recently developed system in which the PCR reaction solutions are reciprocally driven over numerous preheated zones and encapsulated on a chip within an extremely thin flow channel. GeneSoC is available for multiplex real-time PCR and is capable of concurrently detecting 3 fluorescence channels. It is regarded as an excellent alternative diagnostic technology for the detection of influenza A and B viruses, as it completes the real-time RT-PCR reaction in ~16 minutes. Further, the application of PCR technologies is also increasing in clinical microbiology, virology, parasitology, biotechnology, and allied fields due to the simple, rapid, and highly specific screening enabled by this tool. Thus, the growing preference for PCR as a diagnostic and clinical tool is expected to provide lucrative opportunities to the rapid test kits market during the forecast period. South & Central America Rapid Test Kit Market Overview According to the World Health Organization (WHO), Brazil is among the 20 countries with a high prominence rate of tuberculosis. Brazil accounted for 33% of total cases reported in 2020. In 2021, Brazil recorded 68,271 new TB cases, which corresponds to an incidence rate of 32 cases per 100,000 people. TB incidence is slowly increasing owing to an upward trend in Brazil. In Brazil, the Xpert MTB/RIF assay-a rapid molecular test for tuberculosis (RMT-TB)-is used to diagnose new cases of pulmonary and laryngeal tuberculosis in adults and adolescents. During the COVID-19 pandemic in Brazil, the country's Health Ministry issued around a third of the 22.9 million RT-PCR test kits. The federal government provided 6.43 million real-time PCR assays for detecting SARS-CoV-2 in the states. Several players in Brazil are involved in the manufacturing of rapid test kits. Thus, the aforementioned factors are likely to contribute to the rapid test kits market growth. South & Central America Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million) South & Central America Rapid Test Kit Market Segmentation The South & Central America rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the South & Central America rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022. In terms of product, the South & Central America rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022. By technology, the South & Central America rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022. Based on application, the South & Central America rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022. In terms of end user, the South & Central America rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022. Based on country, the South & Central America rapid test kit market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America rapid test kit market share in 2022. F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, Guangzhou Wondfo Biotech Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the South & Central America rapid test kit market. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. South & Central America Rapid Test Kits Market - Key Industry Dynamics 4.1 Market Drivers 4.1.1 Rising Prevalence of Genetic and Infectious Diseases 4.1.2 Strategic Initiatives by Manufacturers 4.2 Market Restraints 4.2.1 Uncertainties Related to Accuracy of Results 4.3 Market Opportunities 4.3.1 Increasing Preference for PCR Techniques 4.4 Future Trends 4.4.1 Innovations in Rapid Antigen Tests 4.5 Impact Analysis 5. Rapid Test Kits Market - South & Central America Market Analysis 5.1 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030 6. South & Central America Rapid Test Kits Market Analysis - by Type 6.1 Overview 6.2 Rapid Antigen Testing 6.2.1 Overview 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 6.3 Rapid Antibody Testing 6.3.1 Overview 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 6.4 Others 6.4.1 Overview 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 7. South & Central America Rapid Test Kits Market Analysis - by Product 7.1 Overview 7.2 Over-the-Counter Rapid Testing Kit 7.2.1 Overview 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 7.3 Professional Rapid Testing Kit 7.3.1 Overview 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 8. South & Central America Rapid Test Kits Market Analysis - by Technology 8.1 Overview 8.2 Lateral Flow Assay 8.2.1 Overview 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 8.3 Solid Phase 8.3.1 Overview 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 8.4 Agglutination 8.4.1 Overview 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 8.5 Immunospot Assay 8.5.1 Overview 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 8.6 Cellular-Component Based 8.6.1 Overview 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 9. South & Central America Rapid Test Kits Market Analysis - by Application 9.1 Overview 9.2 Blood Glucose Testing 9.2.1 Overview 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 9.3 Infectious Disease Testing 9.3.1 Overview 9.3.2 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million) 9.3.3 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 9.4 Cardiometabolic Testing 9.4.1 Overview 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 9.5 Pregnancy and Fertility 9.5.1 Overview 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 9.6 Others 9.6.1 Overview 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 10. South & Central America Rapid Test Kits Market Analysis - by End User 10.1 Overview 10.2 Hospital and Clinics 10.2.1 Overview 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 10.3 Diagnostic Centers 10.3.1 Overview 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 10.4 Home-Care 10.4.1 Overview 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 10.5 Others 10.5.1 Overview 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 11. South & Central America Rapid Test Kits Market - Country Analysis 11.1 South & Central America 11.1.1 Overview 11.1.2 South & Central America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country 11.1.2.1 Brazil 11.1.2.1.1 Overview 11.1.2.2 Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 11.1.2.2.1 Brazil: Rapid Test Kits Market Breakdown, by Type 11.1.2.2.2 Brazil: Rapid Test Kits Market Breakdown, by Product 11.1.2.2.3 Brazil: Rapid Test Kits Market Breakdown, by Technology 11.1.2.2.4 Brazil: Rapid Test Kits Market Breakdown, by Application 11.1.2.2.4.1 Brazil: Rapid Test Kits Market Breakdown, by Infectious Disease Testing 11.1.2.2.5 Brazil: Rapid Test Kits Market Breakdown, by End User 11.1.2.3 Argentina 11.1.2.3.1 Overview 11.1.2.4 Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 11.1.2.4.1 Argentina: Rapid Test Kits Market Breakdown, by Type 11.1.2.4.2 Argentina: Rapid Test Kits Market Breakdown, by Product 11.1.2.4.3 Argentina: Rapid Test Kits Market Breakdown, by Technology 11.1.2.4.4 Argentina: Rapid Test Kits Market Breakdown, by Application 11.1.2.4.4.1 Argentina: Rapid Test Kits Market Breakdown, by Infectious Disease Testing 11.1.2.4.5 Argentina: Rapid Test Kits Market Breakdown, by End User 11.1.2.5 Rest of South & Central America 11.1.2.5.1 Overview 11.1.2.6 Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 11.1.2.6.1 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Type 11.1.2.6.2 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Product 11.1.2.6.3 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Technology 11.1.2.6.4 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Application 11.1.2.6.4.1 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Infectious Disease Testing 11.1.2.6.5 Rest of South & Central America: Rapid Test Kits Market Breakdown, by End User 12. Industry Landscape 12.1 Overview 12.2 Growth Strategies in the Rapid Test Kit Market 12.3 Inorganic Growth Strategies 12.3.1 Overview 12.4 Organic Growth Strategies 12.4.1 Overview 13. Company Profiles 13.1 F. Hoffmann-La Roche Ltd 13.1.1 Key Facts 13.1.2 Business Description 13.1.3 Products and Services 13.1.4 Financial Overview 13.1.5 SWOT Analysis 13.1.6 Key Developments 13.2 Becton Dickinson and Co 13.2.1 Key Facts 13.2.2 Business Description 13.2.3 Products and Services 13.2.4 Financial Overview 13.2.5 SWOT Analysis 13.2.6 Key Developments 13.3 ARKRAY Inc 13.3.1 Key Facts 13.3.2 Business Description 13.3.3 Products and Services 13.3.4 Financial Overview 13.3.5 SWOT Analysis 13.3.6 Key Developments 13.4 Fujirebio Europe NV 13.4.1 Key Facts 13.4.2 Business Description 13.4.3 Products and Services 13.4.4 Financial Overview 13.4.5 SWOT Analysis 13.4.6 Key Developments 13.5 bioMerieux SA 13.5.1 Key Facts 13.5.2 Business Description 13.5.3 Products and Services 13.5.4 Financial Overview 13.5.5 SWOT Analysis 13.5.6 Key Developments 13.6 Cepheid 13.6.1 Key Facts 13.6.2 Business Description 13.6.3 Products and Services 13.6.4 Financial Overview 13.6.5 SWOT Analysis 13.6.6 Key Developments 13.7 Meril Life Sciences Pvt Ltd 13.7.1 Key Facts 13.7.2 Business Description 13.7.3 Products and Services 13.7.4 Financial Overview 13.7.5 SWOT Analysis 13.7.6 Key Developments 13.8 QIAGEN NV 13.8.1 Key Facts 13.8.2 Business Description 13.8.3 Products and Services 13.8.4 Financial Overview 13.8.5 SWOT Analysis 13.8.6 Key Developments 13.9 Guangzhou Wondfo Biotech Co Ltd 13.9.1 Key Facts 13.9.2 Business Description 13.9.3 Products and Services 13.9.4 Financial Overview 13.9.5 SWOT Analysis 13.9.6 Key Developments 13.10 Abbott Laboratories 13.10.1 Key Facts 13.10.2 Business Description 13.10.3 Products and Services 13.10.4 Financial Overview 13.10.5 SWOT Analysis 13.10.6 Key Developments 13.11 Trinity Biotech Plc 13.11.1 Key Facts 13.11.2 Business Description 13.11.3 Products and Services 13.11.4 Financial Overview 13.11.5 SWOT Analysis 13.11.6 Key Developments 13.12 Bio-Rad Laboratories Inc 13.12.1 Key Facts 13.12.2 Business Description 13.12.3 Products and Services 13.12.4 Financial Overview 13.12.5 SWOT Analysis 13.12.6 Key Developments 13.13 Hologic Inc 13.13.1 Key Facts 13.13.2 Business Description 13.13.3 Products and Services 13.13.4 Financial Overview 13.13.5 SWOT Analysis 13.13.6 Key Developments 13.14 DiaSorin SpA 13.14.1 Key Facts 13.14.2 Business Description 13.14.3 Products and Services 13.14.4 Financial Overview 13.14.5 SWOT Analysis 13.14.6 Key Developments 13.15 Premier Medical Corp Pvt Ltd 13.15.1 Key Facts 13.15.2 Business Description 13.15.3 Products and Services 13.15.4 Financial Overview 13.15.5 SWOT Analysis 13.15.6 Key Developments 13.16 Beckman Coulter Inc 13.16.1 Key Facts 13.16.2 Business Description 13.16.3 Products and Services 13.16.4 Financial Overview 13.16.5 SWOT Analysis 13.16.6 Key Developments 14. Appendix 14.1 About The Insight Partners
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
The Insight Partners 社の最新刊レポート
本レポートと同じKEY WORD(antibody)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/08 10:26 148.90 円 163.91 円 197.75 円 |